Thoracoabdominal Asynchrony and Respiratory Distress

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age28-17
SponsorMassachusetts General Hospital

About this trial

The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions.

AIMS To determine if the TAA-monitoring device can be used to detect differences in respiratory synchrony in a manner that is clinically applicable. The investigators hope that the device will detect 1) major asynchrony events in a timely manner so as to prompt clinician intervention during future use; and 2) asynchrony events that may be less visible to the naked eye that may be precursors to more severe events.

Eligibility criteria

Qualifiers

patients 28-days to 17-years of age

who have respiratory distress and those who do not have respiratory distress

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Objectively monitoring thoracoabdominal asynchrony

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators